Effectiveness and safety of pyrotinib‐based therapy in patients with HER2‐positive metastatic breast cancer: A real‐world retrospective study

The previous studies had demonstrated the promising effectiveness and acceptable safety of pyrotinib in patients with HER2‐positive metastatic breast cancer. We aimed to investigate the real‐world data of pyrotinib in complex clinical practice and complement the findings of clinical trials. Two hund...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chao, Bian, Xiaoli, Liu, Zhaoyun, Wang, Xinzhao, Song, Xiang, Zhao, Wei, Liu, Yansong, Yu, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633258/
https://www.ncbi.nlm.nih.gov/pubmed/34672424
http://dx.doi.org/10.1002/cam4.4335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633258/
https://www.ncbi.nlm.nih.gov/pubmed/34672424
http://dx.doi.org/10.1002/cam4.4335

Ejemplares similares